Remove 2011 Remove Biosimilars Remove Communication
article thumbnail

Educating Patients about Generic Drugs: Strategies for Success

Drug Patent Watch

When educating elderly patients: Be patient and take extra time to explain concepts Use larger print materials for easier reading Address concerns about changes in pill appearance or packaging Communicating with Young Adults Younger patients may be more open to generic drugs but might lack knowledge about how they work. ” FDA.gov, 2021.

article thumbnail

Go-To-Patient Strategy- 2033

PharmaState Academy

Communicate with patients and caregivers-at-home in a simple language Communicate with patients and caregivers-at-home in a very simple manner. which sells sophisticated products using simple communication. a pharmaco strong in biopharmaceuticals or biosimilars can work closely with banks. Do not be myopic.

article thumbnail

Skinny Label and Induced Infringement: The Saga Continues

FDA Law Blog: Biosimilars

No reasonable jury could have concluded that the carved-out labeling for petitioner’s generic carvedilol from 2007-2011 was itself evidence of intent to induce infringement.”